Skip to main content
Top
Published in: International Journal of Hematology 4/2003

01-11-2003 | Case Report

Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)

Authors: Hiroya Tamaki, Machiko Mishima, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Kazuhiro Ikegame, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Kazuoki Osumi, Toshihiro Soma, Yusuke Oji, Yoshihiro Oka, Ichiro Kawase, Haruo Sugiyama, Hiroyasu Ogawa

Published in: International Journal of Hematology | Issue 4/2003

Login to get access
Metadata
Title
Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
Authors
Hiroya Tamaki
Machiko Mishima
Manabu Kawakami
Akihiro Tsuboi
Eui Ho Kim
Naoki Hosen
Kazuhiro Ikegame
Masaki Murakami
Tatsuya Fujioka
Tomoki Masuda
Yuki Taniguchi
Sumiyuki Nishida
Kazuoki Osumi
Toshihiro Soma
Yusuke Oji
Yoshihiro Oka
Ichiro Kawase
Haruo Sugiyama
Hiroyasu Ogawa
Publication date
01-11-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983561

Other articles of this Issue 4/2003

International Journal of Hematology 4/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine